Amgen Inc received approval from the U.S. Food and Drug Administration for its cancer drug, Lumakras (sotorasib) as the first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic...
Bristol Myers Squibb (BMS) will gain the global rights to Agenus’ investigational cancer drug, AGEN1777, in a deal worth up to $1.38 billion.
Under the licensing agreement, BMS will spearhead development and commercialization of...
Johnson & Johnson COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization, following a decision from the United States Centers for Disease Control (CDC) and Food...
Both the FDA and Centers for Disease Control have decided to stop administering Johnson & Johnson’s Covid-19 vaccine after reviewing data involving six reported cases of a rare and severe type of blood clot in individuals in...
Researchers may have a real shot at creating an oral COVID-19 vaccine, one that can protect against variants. A pill can be self-administered anywhere, anytime providing access to those in remote locations and the most vulnerable who...
Citing data from Israel, Pfizer and BioNTech said
their COVID-19 vaccine was 94% effective in preventing asymptomatic infection,
but their announcement lacked key details. These new data build upon and
confirm previously released data from the Israel Ministry of Health...
Pharma giant, Merck is supporting efforts to expand the manufacturing capacity and supply of COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority (BARDA), a division of the Office of the Assistant Secretary for Preparedness...
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the...
Several recent publications have now highlighted the damaging role of proteins called extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in COVID-19 infections. In a comprehensive report published in the high impact journal CELL, of over 5,000 proteins identified as perturbed in COVID-19...
